Guselkumab Biosimilar – Anti-IL23A mAb – Research Grade

Reference:

General information on Anti-IL23A[Homo sapiens] (Guselkumab) Monoclonal Antibody

Guselkumab is a human IgG1? monoclonal antibody that targets interleukin-23. IL-23 is an inflammatory cytokine that is reponsible for the activation of the CD4+ T-helper (Th17) cell pathway in the inflammatory cascade that induces psoriatic plaque formation. Guselkumab has been used to treat psoriasis. It has been sold under the trade name Tremfya.

Product nameGuselkumab Biosimilar - Anti-IL23A mAb - Research Grade
SourceCAS 1350289-85-8
SpeciesHomo sapiens
Expression systemMammalian cells
Molecular weight143kDa
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsCNTO-1959
ReferencePX-TA1327
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-lambda
ClonalityMonoclonal Antibody
SourceCAS 1350289-85-8

This is an array with variations 107765

Example of variation sku PX-TA1327-100UG

Example of variation price 300

This is an array with variations 107766

Example of variation sku PX-TA1327-1000UG

Example of variation price 900

Contact us to order

+33 (0)3 90 20 54 70

Write us

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Guselkumab Biosimilar – Anti-IL23A mAb – Research Grade”

Your email address will not be published.

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.